Epithelial cells and osteoclasts

The term 'Epithelial cells and osteoclasts' refers to two distinct biological cell types rather than a specific molecular target such as a receptor or enzyme. Epithelial cells form the protective layers of the body's surfaces and organs, while osteoclasts are specialized multinucleated cells responsible for bone resorption and remodeling (StatPearls, 2023). These cell types are frequently grouped in scientific literature because they share high expression of certain therapeutic targets, most notably Cathepsin K, Src kinase, and the RANK/RANKL signaling system (Open Exploration, 2024; PMC, 2008). For example, Cathepsin K is a cysteine protease primarily found in osteoclasts and certain epithelial cells, making it a target for treating osteoporosis and bone metastasis (Open Exploration, 2024). Similarly, the RANKL pathway stimulates the migration of both RANK-expressing tumor epithelial cells and osteoclasts (Anticancer Research, 2013). Drugs like dasatinib target Src kinase, which is highly present in both prostate cancer epithelial cells and osteoclasts, thereby inhibiting both tumor growth and bone destruction (PMC, 2008). Because this entry describes a cellular population rather than a discrete molecule, it is classified as an incorrect target designation for structured drug discovery databases.

Other names

Epithelium and bone-resorbing cells

Drugs associated with these cell types typically target specific proteins such as RANKL, Cathepsin K, or Src kinase to inhibit bone resorption or tumor cell migration.